Viriom's primary focus is on combatting infectious diseases globally, with an emphasis on treatment, prevention, and elimination. The company is dedicated to pioneering and making available cutting-edge, cost-effective solutions to significantly enhance the worldwide accessibility to superior antiviral therapies. Viriom's extensive, exclusive, and collaborative pipeline encompasses medicinal products for HIV, viral hepatitis, influenza, coronaviruses, and other harmful infectious diseases.